Dr. Agarwals Health Care Ltd
Consolidated and Standalone Unaudited Financial Results of the Company for the quarter ended June 30, 2026 is submitted.
RESULTS
▲ Positive Development
LOW RISK
📅 Filed on BSE: 04 Aug 2026, 02:03 PM IST · BSE ID: 74f27462-e928-46ee-9027-6e54260f1586
View Original BSE Filing (PDF)
💡
In Simple Terms
The company reported strong quarterly financial results, grew its network, and announced plans for a new Nigerian subsidiary.
🤖 AI Summary
- Consolidated Revenue from Operations for Q1 FY27 grew 26.0% YoY to ₹614 Crores.
- Profit After Tax (PAT) for Q1 FY27 increased 44.6% YoY to ₹55 Crores.
- Network expanded to 304 facilities, with 18 new additions and 91,082 surgeries performed in Q1 FY27.
- Board approved appointment of M/s. S.R. Batliboi & Associates LLP as Statutory Auditors until 20th AGM.
- Company plans to incorporate a new wholly-owned step-down subsidiary in Nigeria.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Consolidated Revenue From Operations
₹614 Crores
26.0%
Consolidated Total Income
₹620 Crores
23.9%
Consolidated EBITDA
₹177 Crores
25.2%
Consolidated Profit After Tax
₹55 Crores
44.6%
Total Facilities (as of June 30, 2026)
304 facilities
New Facilities Added (Q1 FY27)
18 facilities
Surgeries Performed (Q1 FY27)
91,082 surgeries
15.5%
🏢 How This Affects the Company
The addition of 18 new facilities and 16 new surgical facilities in Q1 FY27 expands the company's service delivery capacity and geographic reach, supporting future revenue growth. The proposed Nigerian subsidiary indicates international market expansion.
Consolidated Revenue from Operations increased to ₹614 Crores, and Profit After Tax rose to ₹55 Crores in Q1 FY27, indicating improved financial performance and profitability margins. EBITDA margins remained stable at 28.5%.
The addition of 18 new facilities and 91,082 surgeries performed in Q1 FY27 indicates an expansion of operational scale and service volume. The appointment of new internal and cost auditors aims to strengthen financial governance.
The incorporation of a new wholly-owned subsidiary in Nigeria introduces new operational and regulatory compliance considerations in an international market.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this filing.
👤
Who Is Affected
Shareholders are affected by the company's financial performance, including a 44.6% YoY increase in Profit After Tax to ₹55 Crores. The planned Nigerian subsidiary could impact future international growth.
🔍
Management Signal
Management is signaling a focus on aggressive operational expansion, evidenced by 18 new facilities and plans for international subsidiary incorporation, alongside maintaining profitability.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q2 FY27 financial results — observe revenue and profit growth trends.
Updates on the incorporation of the wholly-owned subsidiary in Nigeria.
Details regarding the 20th Annual General Meeting for auditor re-appointment.
LOW RISK
The filing indicates strong financial performance and planned expansion, with no immediate adverse risks.
💡 Investor Takeaway
Dr. Agarwals Health Care Ltd reported Q1 FY27 consolidated Revenue from Operations of ₹614 Crores, a 26.0% YoY increase, with Profit After Tax rising 44.6% YoY to ₹55 Crores. The network expanded to 304 facilities, including 18 new additions, and the company plans to establish a wholly-owned subsidiary in Nigeria.
⚖️ Strengths & Concerns
✅ Positives
- Consolidated Revenue from Operations for Q1 FY27 increased by 26.0% YoY to ₹614 Crores.
- Consolidated Profit After Tax for Q1 FY27 grew 44.6% YoY to ₹55 Crores.
📅 Company Track Record
In Q1 FY27, Dr. Agarwals Health Care reported a 26.0% YoY revenue increase to ₹614 Crores, following a 20.9% YoY total income growth in FY26 to INR 2,125 crores. Q1 FY27 PAT was ₹55 Crores, up 44.6% YoY, building on previous positive profit trends.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What were Dr. Agarwals Health Care's consolidated revenues for Q1 FY27?
Dr. Agarwals Health Care reported consolidated Revenue from Operations of ₹614 Crores for the quarter ended June 30, 2026, marking a 26.0% increase year-on-year.
What was the Profit After Tax (PAT) for Dr. Agarwals Health Care in Q1 FY27?
The consolidated Profit After Tax for Dr. Agarwals Health Care in Q1 FY27 was ₹55 Crores, representing a 44.6% growth compared to the prior year period.
How many facilities did Dr. Agarwals Health Care have as of June 30, 2026?
As of June 30, 2026, Dr. Agarwals Health Care's network comprised 304 facilities, with 18 new facilities added during Q1 FY27.
Did Dr. Agarwals Health Care announce any new subsidiaries in this filing?
Yes, Dr. Agarwals Health Care's direct wholly-owned subsidiary, Orbit Healthcare Services (Mauritius) Limited, plans to incorporate a new wholly-owned step-down subsidiary in Nigeria.
Who was appointed as the Statutory Auditor for Dr. Agarwals Health Care?
M/s. S.R. Batliboi & Associates LLP, Chartered Accountants, were appointed as the Statutory Auditors of Dr. Agarwals Health Care, to hold office until the conclusion of the 20th Annual General Meeting.
Questions based on this BSE filing only. For information purposes.